Cover Image

Corrigendum: Improving therapy of pharmacoresistant epilepsies: The role of fenfluramine

Saved in:

Bibliographic Details
Main Authors:	Gianluca Dini (Author), Eleonora Tulli (Author), Giovanni Battista Dell'Isola (Author), Elisabetta Mencaroni (Author), Giuseppe Di Cara (Author), Pasquale Striano (Author), Alberto Verrotti (Author)
Format:	Book
Published:	Frontiers Media S.A., 2023-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Improving Therapy of Pharmacoresistant Epilepsies: The Role of Fenfluramine
by: Gianluca Dini, et al.
Published: (2022)

Expanding the genetic and clinical characteristics of Protocadherin 19 gene mutations
by: Giovanni Battista Dell'Isola, et al.
Published: (2022)

Therapeutic Options for Childhood Absence Epilepsy
by: Victoria Elisa Rinaldi, et al.
Published: (2021)

Todd Paralysis in Rolandic Epilepsy
by: Pasquale Striano, et al.
Published: (2015)

Cannabidiol Treatment for Refractory Epilepsies in Pediatrics
by: Umberto Raucci, et al.
Published: (2020)

Fenfluramine: A Review of Pharmacology, Clinical Efficacy, and Safety in Epilepsy
by: Debopam Samanta
Published: (2022)

Lower fat and better quality diet therapy for children with pharmacoresistant epilepsy
by: Jung-Rim Yoon, et al.
Published: (2013)

A Volumetric Absorptive Microsampling Technique to Monitor Cannabidiol Levels in Epilepsy Patients
by: Sara Dubois, et al.
Published: (2020)

Gephyrin and CYP2C9 Genetic Polymorphisms in Patients with Pharmacoresistant Epilepsy
by: El-Tallawy HN, et al.
Published: (2021)

Cannabidiol in Pharmacoresistant Epilepsy: Clinical Pharmacokinetic Data From an Expanded Access Program
by: Manuela Contin, et al.
Published: (2021)

Current Overview of CDKL-5 Deficiency Disorder Treatment
by: Giovanni Battista Dell'Isola, et al.
Published: (2024)

Is benign familial neonatal KCNQ2-related epilepsy always familially benign?
by: Piero Pavone, et al.
Published: (2018)

Fenfluramine: a plethora of mechanisms?
by: Jo Sourbron, et al.
Published: (2023)

Symptomatic eating epilepsy: two novel pediatric patients and review of literature
by: Fabiana Vercellino, et al.
Published: (2021)

Fenfluramine Add-On Therapy of Dravet Syndrome
by: J Gordon Millichap
Published: (2012)

A review of safety and efficacy of zonisamide for treatment of pediatric partial epilepsy
by: Vari MS, et al.
Published: (2014)

The complexity of roles of P-glycoprotein in refractory epilepsy: Pharmacoresistance, epileptogenesis, SUDEP and relapsing marker after surgical treatment
by: Alberto Lazarowski, et al.
Published: (2015)

Cannabidiol, ∆9-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients
by: Federica Pigliasco, et al.
Published: (2022)

1,2,4-Triazole-based anticonvulsant agents with additional ROS scavenging activity are effective in a model of pharmacoresistant epilepsy
by: Barbara Kaproń, et al.
Published: (2020)

Case report: Structural brain abnormalities in TUBA1A-tubulinopathies: a narrative review
by: Piero Pavone, et al.
Published: (2023)

In vitro evaluation of fenfluramine and norfenfluramine as victims of drug interactions
by: Parthena Martin, et al.
Published: (2022)

A review of fenfluramine for the treatment of Dravet syndrome patients
by: Kayla Simon, et al.
Published: (2022)

Efficacy and safety of fenfluramine in the treatment of Dravet syndrome - literature review
by: Martyna Stefaniak, et al.
Published: (2022)

Acute Neurological Presentation in Children With SARS-CoV-2 Infection
by: Antonella Riva, et al.
Published: (2022)

Giving an account of patients' experience: A qualitative study on the care process of hip and knee osteoarthritis
by: Simone Battista, et al.
Published: (2022)

UHPLC-MS/MS Analysis of Cannabidiol and Its Metabolites in Serum of Patients with Resistant Epilepsy Treated with CBD Formulations
by: Sara Malaca, et al.
Published: (2021)

The microbiota‐gut‐brain axis and epilepsy from a multidisciplinary perspective: Clinical evidence and technological solutions for improvement of in vitro preclinical models
by: Federica Fusco, et al.
Published: (2022)

Targeted re-sequencing for early diagnosis of genetic causes of childhood epilepsy: the Italian experience from the 'beyond epilepsy' project
by: Elisabetta Amadori, et al.
Published: (2020)

Essential headaches in developmental age: What is changed before, during and after the lockdown for COVID-19 pandemic. Clinical study
by: Alice Bonuccelli, et al.
Published: (2023)

In vitro evaluation suggests fenfluramine and norfenfluramine are unlikely to act as perpetrators of drug interactions
by: Parthena Martin, et al.
Published: (2022)

A dramatic EEG response to fenfluramine in a patient with developmental and epileptic encephalopathy
by: Douglas R. Nordli III, et al.
Published: (2024)

Detention and incompatibility of HIV patients in Italy
by: Serena Dell'Isola, et al.
Published: (2013)

Case report: Revascularization failure in NF1-related moyamoya syndrome after selumetinib: A possible pathophysiological correlation?
by: Cristina Chelleri, et al.
Published: (2023)

Impact and management of drooling in children with neurological disorders: an Italian Delphi consensus
by: Antonella Riva, et al.
Published: (2022)

Chapter Sviluppare identità di persone che apprendono
by: Striano, Maura
Published: (2022)

Chapter Higher Education and Work-Related Learning from Professionalism to Professionality
by: Striano, Maura
Published: (2018)

Chapter Sviluppare identità di persone che apprendono
by: Striano, Maura
Published: (2022)

Chapter Higher Education and Work-Related Learning from Professionalism to Professionality
by: Striano, Maura
Published: (2018)

Università oggi: problemi aperti
by: Maura Striano
Published: (2019)

How "Pharmacoresistant" is Cav2.3, the Major Component of Voltage-Gated R-type Ca2+ Channels?
by: Jürgen Hescheler, et al.
Published: (2013)